Reference
Eder L, et al. Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension. RMD Open 9 : 1-12, No. 1, Feb 2023. Available from: URL: 10.1136/rmdopen-2022-002718
Rights and permissions
About this article
Cite this article
Adalimumab/tofacitinib. Reactions Weekly 2002, 23 (2024). https://doi.org/10.1007/s40278-024-55400-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-55400-3